Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting

被引:5
|
作者
Chechetkin, Vladimir R. [1 ]
Lobzin, Vasily V. [2 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov Str 32, Moscow, Russia
[2] Univ Sydney, Sch Phys, Sydney, NSW, Australia
关键词
COVID-19; SARS-CoV; SARS-CoV-2; helical nucleocapsid; genome packaging; ESTERASE GENE-CLUSTER; NUCLEOCAPSID PROTEIN; DNA; IDENTIFICATION; SEQUENCES; SEARCH; PERIODICITIES; ARCHITECTURE; RECOGNITION; ENTROPY;
D O I
10.1080/07391102.2020.1815581
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genomic ssRNA of coronaviruses is packaged within a helical nucleocapsid. Due to transitional symmetry of a helix, weakly specific cooperative interaction between ssRNA and nucleocapsid proteins leads to the natural selection of specific quasi-periodic assembly/packaging signals in the related genomic sequence. Such signals coordinated with the nucleocapsid helical structure were detected and reconstructed in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2. The main period of the signals for both viruses was about 54 nt, that implies 6.75 nt per N protein. The complete coverage of the ssRNA genome of length about 30,000 nt by the nucleocapsid would need 4.4 x 10(3)N proteins, that makes them the most abundant among the structural proteins. The repertoires of motifs for SARS-CoV and SARS-CoV-2 were divergent but nearly coincided for different isolates of SARS-CoV-2. We obtained the distributions of assembly/packaging signals over the genomes with nonoverlapping windows of width 432 nt. Finally, using the spectral entropy, we compared the load from point mutations and indels during virus age for SARS-CoV and SARS-CoV-2. We found the higher mutational load on SARS-CoV. In this sense, SARS-CoV-2 can be treated as a 'newborn' virus. These observations may be helpful in practical medical applications and are of basic interest. Communicated by Ramaswamy H. Sarma
引用
收藏
页码:508 / 522
页数:15
相关论文
共 50 条
  • [41] SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
    Elshabrawy, Hatem A.
    VACCINES, 2020, 8 (02) : 1 - 33
  • [42] Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
    Prates, Erica T.
    Garvin, Michael R.
    Pavicic, Mirko
    Jones, Piet
    Shah, Manesh
    Demerdash, Omar
    Amos, B. Kirtley
    Geiger, Armin
    Jacobson, Daniel
    MOLECULAR BIOLOGY AND EVOLUTION, 2021, 38 (02) : 702 - 715
  • [43] Analysis and comparison of physiochemical properties, mutations and glycosylation patterns between RNA polymerase and membrane protein of SARS-CoV and SARS-CoV-2
    Behbahani, Mandana
    Rabiei, Parisa
    Mohabatkar, Hassan
    MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2021, 10 (04) : 171 - 178
  • [44] Uncovering the morphological differences between SARS-CoV-2 and SARS-CoV based on transmission electron microscopy images
    Taha, Bakr Ahmed
    Al Mashhadany, Yousif
    Al-Jubouri, Qussay
    Haider, Adawiya J.
    Chaudhary, Vishal
    Apsari, Retna
    Arsad, Norhana
    MICROBES AND INFECTION, 2023, 25 (08)
  • [45] Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV
    Ayouba, Ahidjo
    Thaurignac, Guillaume
    Morquin, David
    Tuaillon, Edouard
    Raulino, Raisa
    Nkuba, Antoine
    Lacroix, Audrey
    Vidal, Nicole
    Foulongne, Vincent
    Le Moing, Vincent
    Reynes, Jacques
    Delaporte, Eric
    Peeters, Martine
    JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [46] Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
    Yue, Can
    Wang, Pengyan
    Tian, Jinmin
    Gao, George F.
    Liu, Kefang
    Liu, William J.
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (13): : 4052 - 4060
  • [47] Recombination in Coronaviruses, with a Focus on SARS-CoV-2
    Focosi, Daniele
    Maggi, Fabrizio
    VIRUSES-BASEL, 2022, 14 (06):
  • [48] Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2)
    Rabaan, A. A.
    Mutair, A. A.
    Alawi, Z. A.
    Alhumaid, S.
    Mohaini, M. A.
    Aldali, J.
    Tirupathi, R.
    Sule, A. A.
    Koritala, T.
    Adhikari, R.
    Bilal, M.
    Dhawan, M.
    Mohapatra, R. K.
    Tiwari, R.
    Sami, S. A.
    Mitra, S.
    Pandey, M. K.
    Harapan, H.
    Emran, T. B.
    Dhama, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (22) : 7162 - 7184
  • [49] Setu: a pipeline for the robust assembly of SARS-CoV-2 genomes
    Shukla, Nityendra
    Srivastava, Neha
    Srivastava, Prachi
    Narayan, Jitendra
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2024, 13 (07):
  • [50] Coronaviruses and SARS-CoV-2: A Brief Overview
    Ludwig, Stephan
    Zarbock, Alexander
    ANESTHESIA AND ANALGESIA, 2020, 131 (01) : 93 - 96